Evidence map›Paper›PMID 37737916›Full record

ReviewIrish journal of medical science2024

Cardiac myxomas: causes, presentations, diagnosis, and management.

Elio Assaad Saad, Tishya Mukherjee, Georges Gandour, Nora Fatayerji, Aya Rammal, Peter Samuel, Nicolas Abdallah, Tejaswini Ashok

Abstract readReview
PubMed Publisher
In one paragraph

Review in Irish journal of medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comparative outcomes of robotic surgeryWorld journal of cardiology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Brain metastases in a patient with antecedent of cardiac myxoma: a case report and review of literatureRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2024
    Review
  9. Article
  10. Right Atrium Primary Cardiac Lymphoma Causing Heart Failure.The Thoracic and cardiovascular surgeon reports · 2024
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Elio Assaad SaadFaculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Lebanon.ORCID http://orcid.org/0000-0002-7475-1777
Tishya MukherjeeFaculty of Medicine, Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, Moldova.
Georges GandourFaculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Lebanon.
Nora FatayerjiFaculty of Medicine and Medical Sciences, Poznan University of Medical Sciences, Poznan, Poland.
Aya RammalFaculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Peter SamuelInternational Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia. samuelhpeter@gmail.com.ORCID http://orcid.org/0000-0002-0840-032X
Nicolas AbdallahFaculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Lebanon.
Tejaswini AshokJSS Medical College, Mysore, Karnataka, India.
University of Balamand · LBJSS Medical College and Hospital · INNicolae Testemițanu State University of Medicine and Pharmacy · MDPoznan University of Medical Sciences · PLSaint Joseph University · LBTbilisi State Medical University · GE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac myxomas (CM) are one of the most common benign tumors which are typical in adults with a yearly incidence of 0.5-1 case per million individuals. This review article includes discussions based on existing literature on the role of interleukin interactions in the pathophysiology of cardiac myxoma which can lead to embolic complications, aneurysms, and CNS involvement. The objective of this narrative review was to study the variable clinical presentations of cardiac myxoma, its detection and diagnosis involving multiple modalities like genetic and hematological testing, echocardiography, CT, and MRI, of which transoesophageal echocardiogram shows excellent precision with a 90% to 96% accuracy in diagnosing CM. Individuals with the Carney complex are prone to such neoplasia. Cardiac myxomas are challenging to diagnose due to the ambiguity of their differential with thrombi. Myxomas can also be diagnosed by tumor markers like interleukin-6 and endothelial growth factors. The management of CM includes surgical excision like median sternotomy and robotic minimally invasive surgery. The use of robotic surgery in CM increased from 1.8% in 2012 to 15.1% in 2018. Tumor recurrences are uncommon but can occur due to inadequate surgical resection.

Indexed as

Heart NeoplasmsMyxomaAdultEchocardiographyHumansMagnetic Resonance ImagingNeoplasm Recurrence, LocalCardiac myxomaRecurrenceSurgeryTransthoracic echocardiographyTumor

Identifiers

PMID37737916
OpenAlexW4386944667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.